Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0540 Transporter Info
Gene Name	ATP12A
Transporter Name	Potassium-transporting ATPase alpha chain 2
Gene ID	479
UniProt ID	P54707

Post-Translational Modification of This DT
Overview of ATP12A Modification Sites with Functional and Structural Information
Sequence	M H Q K T P E I Y S V E L S G T K D I V K T D K G D G K E K Y R G L K N N C L E L K K K N H K E E F Q K E L H L D D H K L S N R E L E E K Y G T D I I M G L S S T R A A E L L A R D G P N S L T P P K Q T P E I V K F L K Q M V G G F S I L L W V G A F L C W I A Y G I Q Y S S D K S A S L N N V Y L G C V L G L V V I L T G I F A Y Y Q E A K S T N I M S S F N K M I P Q Q A L V I R D S E K K T I P S E Q L V V G D I V E V K G G D Q I P A D I R V L S S Q G C R V D N S S L T G E S E P Q P R S S E F T H E N P L E T K N I C F Y S T T C L E G T V T G M V I N T G D R T I I G H I A S L A S G V G N E K T P I A I E I E H F V H I V A G V A V S I G I L F F I I A V S L K Y Q V L D S I I F L I G I I V A N V P E G L L A T V T V T L S L T A K R M A K K N C L V K N L E A V E T L G S T S I I C S D K T G T L T Q N R M T V A H L W F D N Q I F V A D T S E D H S N Q V F D Q S S R T W A S L S K I I T L C N R A E F K P G Q E N V P I M K K A V I G D A S E T A L L K F S E V I L G D V M E I R K R N R K V A E I P F N S T N K F Q L S I H E M D D P H G K R F L M V M K G A P E R I L E K C S T I M I N G E E H P L D K S T A K T F H T A Y M E L G G L G E R V L G F C H L Y L P A D E F P E T Y S F D I D A M N F P T S N L C F V G L L S M I D P P R S T V P D A V T K C R S A G I K V I M V T G D H P I T A K A I A K S V G I I S A N S E T V E D I A H R L N I A V E Q V N K R D A K A A V V T G M E L K D M S S E Q L D E I L A N Y Q E I V F A R T S P Q Q K L I I V E G C Q R Q D A V V A V T G D G V N D S P A L K K A D I G I A M G I A G S D A A K N A A D M V L L D D N F A S I V T G V E E G R L I F D N L K K T I A Y S L T K N I A E L C P F L I Y I I V G L P L P I G T I T I L F I D L G T D I I P S I A L A Y E K A E S D I M N R K P R H K N K D R L V N Q P L A V Y S Y L H I G L M Q A L G A F L V Y F T V Y A Q E G F L P R T L I N L R V E W E K D Y V N D L K D S Y G Q E W T R Y Q R E Y L E W T G Y T A F F V G I L V Q Q I A D L I I R K T R R N S I F Q Q G L F R N K V I W V G I T S Q I I I G L I L S Y G L G S V T A L S F T M L R A Q Y W F V A V P H A I L I W V Y D E V R K L F I R L Y P G S W W D K N M Y Y
PTM type	X-Acetylation X-Phosphorylation X-S-nitrosylation X-S-palmitoylation X-S-sulfhydration X-Ubiquitination X: Amino Acid

Acetylation
Lysine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ATP12A			[1]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	42
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ATP12A Lysine 42 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ATP12A			[2]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	449
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ATP12A Lysine 449 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ATP12A			[3]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	459
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ATP12A Lysine 459 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ATP12A			[4]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	856
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ATP12A Lysine 856 has the potential to affect its expression or activity.
Phosphorylation
Serine	8 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ATP12A			[5] , [6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	10
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP12A Serine 10 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ATP12A			[6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	14
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP12A Serine 14 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ATP12A			[7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	62
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP12A Serine 62 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ATP12A			[8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	94
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP12A Serine 94 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence ATP12A			[9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	499
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP12A Serine 499 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence ATP12A			[10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	534
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP12A Serine 534 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence ATP12A			[11] , [12]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	623
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP12A Serine 623 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence ATP12A			[13] , [14]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	737
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP12A Serine 737 has the potential to affect its expression or activity.
Threonine	9 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ATP12A			[6] , [12]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	5
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP12A Threonine 5 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ATP12A			[6]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	16
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP12A Threonine 16 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ATP12A			[15]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	362
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP12A Threonine 362 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ATP12A			[16] , [17]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	393
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP12A Threonine 393 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence ATP12A			[17] , [18]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	395
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP12A Threonine 395 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence ATP12A			[17] , [18]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	397
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP12A Threonine 397 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence ATP12A			[10]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	535
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP12A Threonine 535 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence ATP12A			[11] , [19]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	632
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP12A Threonine 632 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence ATP12A			[11] , [12]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	638
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP12A Threonine 638 has the potential to affect its expression or activity.
Tyrosine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ATP12A			[6] , [12]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	9
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP12A Tyrosine 9 has the potential to affect its expression or activity.
S-nitrosylation
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ATP12A			[20]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	720
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-nitrosylation (-SNO) at ATP12A Cystine 720 has the potential to affect its expression or activity.
S-palmitoylation
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ATP12A			[21]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	720
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-palmitoylation at ATP12A Cystine 720 has the potential to affect its expression or activity.
S-sulfhydration
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ATP12A			[22]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	720
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-sulfhydration (-SSH) at ATP12A Cystine 720 has the potential to affect its expression or activity.
Ubiquitination
Lysine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ATP12A			[23] , [24]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	627
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ATP12A Lysine 627 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ATP12A			[23] , [24]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	640
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ATP12A Lysine 640 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ATP12A			[23] , [24]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	713
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ATP12A Lysine 713 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ATP12A			[23] , [24]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	788
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ATP12A Lysine 788 has the potential to affect its expression or activity.

References
1	Regulation of cellular metabolism by protein lysine acetylation. Science. 2010 Feb 19;327(5968):1000-4.
2	Mouse heart rate in a human: diagnostic mystery of an extreme tachyarrhythmia. Indian Pacing Electrophysiol J. 2012 Jan;12(1):32-5.
3	ProPAS: standalone software to analyze protein properties. Bioinformation. 2012;8(3):167-9.
4	dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: AT12A_HUMAN)
5	Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
6	Citric acid-assisted two-step enrichment with TiO2 enhances the separation of multi- and monophosphorylated peptides and increases phosphoprotein profiling. J Proteome Res. 2013 Jun 7;12(6):2467-76.
7	An Augmented Multiple-Protease-Based Human Phosphopeptide Atlas. Cell Rep. 2015 Jun 23;11(11):1834-43.
8	Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach. Anal Chem. 2009 Jun 1;81(11):4493-501.
9	Refined phosphopeptide enrichment by phosphate additive and the analysis of human brain phosphoproteome. Proteomics. 2015 Jan;15(2-3):500-7.
10	iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
11	Tip-Based Fractionation of Batch-Enriched Phosphopeptides Facilitates Easy and Robust Phosphoproteome Analysis. J Proteome Res. 2018 Jan 5;17(1):46-54.
12	Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal. 2010 Jan 12;3(104):ra3.
13	Protein kinase C-alpha interaction with F0F1-ATPase promotes F0F1-ATPase activity and reduces energy deficits in injured renal cells. J Biol Chem. 2015 Mar 13;290(11):7054-66.
14	Improved Method for Determining Absolute Phosphorylation Stoichiometry Using Bayesian Statistics and Isobaric Labeling. J Proteome Res. 2017 Nov 3;16(11):4217-4226.
15	Phosphoproteomic analysis of human embryonic stem cells. Cell Stem Cell. 2009 Aug 7;5(2):204-13.
16	Quantitative phosphoproteomics of Alzheimer's disease reveals cross-talk between kinases and small heat shock proteins. Proteomics. 2015 Jan;15(2-3):508-519.
17	Global Phosphoproteomic Analysis of Human Skeletal Muscle Reveals a Network of Exercise-Regulated Kinases and AMPK Substrates. Cell Metab. 2015 Nov 3;22(5):922-35.
18	Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer. J Proteome Res. 2017 Dec 1;16(12):4364-4373.
19	Toward a comprehensive characterization of a human cancer cell phosphoproteome. J Proteome Res. 2013 Jan 4;12(1):260-71.
20	Dual Labeling Biotin Switch Assay to Reduce Bias Derived From Different Cysteine Subpopulations: A Method to Maximize S-Nitrosylation Detection. Circ Res. 2015 Oct 23;117(10):846-57.
21	Selective Enrichment and Direct Analysis of Protein S-Palmitoylation Sites. J Proteome Res. 2018 May 4;17(5):1907-1922.
22	Direct Proteomic Mapping of Cysteine Persulfidation. Antioxid Redox Signal. 2020 Nov 20;33(15):1061-1076.
23	A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol Cell Proteomics. 2011 Oct;10(10):M111.013284.
24	Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 2011 Oct 21;44(2):325-40.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence